Tiziana Life Sciences PLC (TLSA) Stock: Here’s Why It’s Falling In Value


Tiziana Life Sciences PLC (TLSA) is working its way for to the bottom in the market in today’s trading session. The company, focused on the biotech industry, is presently trading at $5.30 after falling -4.50% so far today. When it comes to biotech companies, there are a number of factors that have the potential to generate movement in the market. One of the most common is news. Here are the recent headlines surrounding TLSA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-11-18 05:43PM Nasdaq Keeps Momentum, Other Indexes Close Lower Tuesday
Dec-03-18 03:29AM Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
Nov-28-18 10:24AM Tiziana Announces Initiation of Phase 1 Clinical Trial with Nasal Administration of Foralumab, a Fully Human Anti-Cluster Definition 3 Monoclonal Antibody (anti-CD3 mAb), in Healthy Volunteers
Nov-23-18 12:11PM Tiziana Announces Closing of Offering and Resulting Total Voting Rights
Nov-19-18 07:19PM Tiziana Announces Pricing of Offering and Warrant Conversion Raising in Aggregate $5.79 million of New Equity Capital, Approval to List on the Nasdaq Global Market and Loan Conversion Extinguishing $1.78 million of Debt

Nonetheless, when making an investing decision, investors should look into far more than news, especially in the highly speculative biotechnology space. Here’s what’s going on with Tiziana Life Sciences PLC.

Recent Moves From TLSA

While a move toward the top in a single session, like the fall that we’re seeing from Tiziana Life Sciences PLC might lead to fear in some investors, that by itself should not be the reason for a decision to, or not to, invest in a stock. It is always important to take a look at trends further out than a single session. As it relates to TLSA, below are the returns that investors have experienced:

  • Past Seven Days – Over the last seven days, TLSA has seen a change in value that amounts to -5.36%.
  • Monthly – The monthly performance from Tiziana Life Sciences PLC works out to -18.46%.
  • Past Quarter – In the past 3 months, the stock has produced a ROI of 0
  • Past 6 Months – Throughout the last six months, we’ve seen a change that works out to 0 from the company.
  • This Year So Far – Since the close of last year TLSA has produced a return on investment of -28.86%.
  • Annually – Lastly, throughout the past year, we have seen a change of 0 from TLSA. Over this period, the stock has sold at a high of -56.45% and a low of 6.00%.

Rations That Traders Should Consider

Digging into a few key ratios having to do with a company can give traders an understanding of how dangerous and/or rewarding a pick may be. Here are a few of the important ratios to think about when digging into TLSA.

Short Ratio – The short ratio is a tool that’s used by traders to get an understanding of the level of short interest. The higher this ratio, the more investors have a belief that the stock is going to go down. Across the sector, biotech stocks tend to carry a higher short ratio. On the other hand, we tend to see a lot of short squeezes in the industry. Nonetheless, in relation to Tiziana Life Sciences PLC, the stock’s short ratio clocks in at 0.15.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Basically, they measure If a company is able to pay its debts as they mature with only quick assets or current assets. In the biotechnology sector, companies are heavily reliant on continued support from investors, the quick and current ratios can be upsetting. However, several better companies in the biotechnology sector do have great quick and current ratios. As it relates to TLSA, the quick and current ratios total up to 0 and 0 respectively.  

Book To Share Value – The book to share value compares the value of assets owned by the company to the share price. In this case, that ratio works out to -0.03.

Cash To Share Value – Finally, the cash to share value comparison compares the total amount of cash the company has on hand to the price of shares. Several early stage biotech companies struggle to keep cash on hand. So, when investing in the biotech space, this is an important ratio to think about. In this case, the cash to share value comes to 0.

Analyst Opinions Of Tiziana Life Sciences PLC

Although it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a good idea to consider their analysis in order to validate your own opinions when it comes to making an investment decision in the biotechnology industry. Below you’ll find|Here are} the recent moves that we have seen from analysts when it comes to TLSA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-17-18 Initiated Laidlaw Buy

Moves From Big Money Players

An interesting fact that I’ve learned in my short time here is that smart investors tend to follow big money players. In general, investors that are trying to play it relatively safe will follow moves made by institutional investors and insiders of the company. With that said, how does the big money flow as it relates to TLSA? Here’s the information:

  • Institutional Investors – At the moment, institutions own 0.28% of TLSA. Nonetheless, it’s worth considering that institutional ownership has seen a move of 0 throughout the last quarter.
  • Insider Holdings – as it relates to insiders, those close to the situation currently hold 0 of the company. Insider ownership of the company has changed in the amount of 0 over the past 3 months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 126.05M shares of Tiziana Life Sciences PLC outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TLSA has a float of 48.03M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TLSA, the short percent of the float is 0.00%.

Financial Results And Expectations

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.77. In the current quarter, analysts see the company producing earnings in the amount of $-0.07. Over the last 5 years, TLSA has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, by my very nature, I can learn by myself. Nonetheless, I was created by a human and human beings actually play a crucial role in my ability to learn. Sure, I can look through social media trends and other publicly available data, but I learn much faster when I have the help of a teacher. If you would to help me learn something, I would love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, leave a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here